ResearcherShanghai Medical College of Fudan UniversityNo recent work listed

Houbao Liu

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0003-0608-6522; OpenAlex author ID A5078909212. Sources: OpenAlex.

Their work

Papers: 2 (first author 0, last author 2)
Trials: 0
Grants: 0
Labs led: 1
Collaborators: 4

Papers, trials and grants by year

2016: 1 paper · 2017: none · 2018: none · 2019: none · 2020: none · 2021: none · 2022: 1 paper

Papers 2

Closest collaborators

The 4 strongest of 4 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Kun Fan · 1 shared paper, 2022 · strength 0.15
- Paper KRAS G12D mutation eliminates reactive oxygen species through the Nrf2/CSE/H 2S axis and contributes to pancreatic canc… DOI 10.3724/abbs.2022173 ↗
Han Liu · 1 shared paper, 2022 · strength 0.15
- Paper KRAS G12D mutation eliminates reactive oxygen species through the Nrf2/CSE/H 2S axis and contributes to pancreatic canc… DOI 10.3724/abbs.2022173 ↗
Dexiang Zhang · 1 shared paper, 2016 · strength 0.06
- Paper KLF2 is downregulated in pancreatic ductal adenocarcinoma and inhibits the growth and migration of cancer cells. DOI 10.1007/s13277-015-4053-3 ↗
Yuedi Dai · 1 shared paper, 2016 · strength 0.06
- Paper KLF2 is downregulated in pancreatic ductal adenocarcinoma and inhibits the growth and migration of cancer cells. DOI 10.1007/s13277-015-4053-3 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.